Search General Info
Search Education
Search Partnering Companies
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death and LLPS fields respectively;
• An integrated and experienced R&D team to support drug development from bench to bedside Liquid-liquid phase separation (LLPS) has been implicated in various diseases including cancer,neurodegenerative diseases, metabolic diseases, etc.;
• Our proprietary LLPS platform enables high throughput discovery of novel drugs targeting “undruggable” proteins such as transcription factors and phosphatases
• Various landmark papers including publication in Cell
• Leading asset is in Phase Ib;
• 3 assets in PCC nomination and IND enabling stage;
• Strategic collaboration with Roche and Lilly on LLPS platform established
• Clinical trial collaboration with MSD initiated
• An integrated and experienced R&D team to support drug development from bench to bedside Liquid-liquid phase separation (LLPS) has been implicated in various diseases including cancer,neurodegenerative diseases, metabolic diseases, etc.;
• Our proprietary LLPS platform enables high throughput discovery of novel drugs targeting “undruggable” proteins such as transcription factors and phosphatases
• Various landmark papers including publication in Cell
• Leading asset is in Phase Ib;
• 3 assets in PCC nomination and IND enabling stage;
• Strategic collaboration with Roche and Lilly on LLPS platform established
• Clinical trial collaboration with MSD initiated
![](https://www.abstractscorecard.com/uploads/Tasks/upload/20525/EOISBJNL-1540971-1-JPG.png)
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
Shanghai
Company HQ Country:
China
Year Founded:
2018
Main Therapeutic Focus:
Oncology
Lead Product in Development:
SHP2, phase I ; ARV-7, IND enabling stage; YAP, IND enabling stage; other severals are at lead optimizaiton stage.
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
5
Speaker
![](https://www.conferenceharvester.com/uploads/harvester/photos/EOISBJNL-Presenter-ZhuJ.png)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved